Market News & Trends
The Medicines Company Licenses BMS' Device for $105 Million
The Medicines Company and Bristol-Myers Squibb Company recently announced that the companies have signed a global license and 2-year collaboration for Recothrom, a recombinant…
12/19/2012
Biogen Idec & Eisai Inc. Form Strategic Alliance Biogen Idec and Eisai Inc. recently announced a strategic alliance that will bolster the manufacturing capabilities of…
Aptalis Pharmaceutical Technologies Announces Approval
Aptalis Pharmaceutical Technologies recently announced that the European Commission granted marketing authorization for a new pediatric indication of a new oral granule formulation of…
Biogen Idec & Eisai Inc. Form Strategic Alliance
Biogen Idec and Eisai Inc. recently announced a strategic alliance that will bolster the manufacturing capabilities of both companies' Research Triangle Park (RTP)-based facilities.…
Catalent & UMN Pharma Announce Biosimilar Development Collaboration
Catalent Pharma Solutions and UMN Pharma Inc. recently announced the signing of an agreement to provide UMN Pharma a broad range of biosimilar cell…
FDA Panel Rejects Painkiller Drug
Zogenix, Inc. recently announced that the US FDA Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) voted 2 to 11 (with one abstention) against…
Ligand Pharmaceuticals & Pfizer Get PDUFA Date
Pfizer Inc. and Ligand Pharmaceuticals Incorporated recently announced that the US FDA accepted for review an NDA for bazedoxifene/conjugated estrogens (BZA/CE), a potential new…
12/12/2012
TNF Inhibitors Lay Groundwork for Next-Generation of Disease-Modifying Anti-Rheumatic Drugs The challenges inherent in the pharmacological management of rheumatic diseases have stoked huge demand for…
Isis Pharmaceuticals Announces $31-Million Strategic Cancer Alliance
Isis Pharmaceuticals, Inc. and AstraZeneca recently announced a strategic alliance for the discovery and development of novel-generation antisense therapeutics against five cancer targets, which includes…
Moderna Therapeutics Secures $40 Million for New Way of Making Therapeutic Proteins
Moderna Therapeutics recently announced it has closed more than $40 million in financing to date, led by Flagship Ventures and private investors, which will be…
New Genomic Biomarker Services to Improve Drug Development Pipelines
EMD Millipore's Discovery and Development Solutions business, part of the Life Science division of Merck KGaA of Darmstadt, Germany, recently announced it will now offer…
Pearl Therapeutics Issued US Patent on Co-Suspension Formulation Technology
Pearl Therapeutics Inc. recently announced that the US Patent and Trademark Office has issued a patent on its novel co-suspension formulation technology for inhaled combinations.…
Teva Enters $376-Million Deal for Xenon's Pain Drug
Teva Pharmaceutical Industries Ltd and Xenon Pharmaceuticals Inc. recently announced they have entered into a collaborative development and exclusive worldwide license for XEN402, which is…
TNF Inhibitors Lay Groundwork for Next-Generation of Disease-Modifying Anti-Rheumatic Drugs
The challenges inherent in the pharmacological management of rheumatic diseases have stoked huge demand for drug classes with excellent safety and efficacy profiles. While tumor…
12/5/2012
Curis Announces Several Major Announcements Curis, Inc. recently announced it has licensed from Genentech, a member of the Roche Group, exclusive worldwide rights for the…
Curis Announces Several Major Announcements
Curis, Inc. recently announced it has licensed from Genentech, a member of the Roche Group, exclusive worldwide rights for the development and commercialization of GDC-0917,…
Governor Jindal, AgraTech International Announce New Chitosan Facility
Governor Bobby Jindal and AgraTech International Inc. Chairman Richard DeMarco recently announced the company will renovate a former Opelousas bottling facility, creating 50 new direct…
Hovione & Solvias Announce Drug Solubility Collaboration
Hovione and Solvias recently announced the establishment of a collaboration focused on the development and GMP supply of pharmaceutical co-crystals. This strengthens Hovione's expertise and…
New Technology for Producing Thermostable Vaccines
Bend Research Inc., PATH, and Fraunhofer USA Center for Molecular Biotechnology (FhCMB) recently announced the development of a new technology for the production of thermostable…
Selecta Biosciences & Sanofi Sign Global Collaboration
Selecta Biosciences, Inc. recently announced it has entered into a strategic global collaboration with Sanofi to discover highly targeted, antigen-specific immunotherapies for life-threatening allergies. Under…
